Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Glioblastoma 1

Interventions

Specimen Handling 280 Magnetic Resonance Spectroscopy 233 pembrolizumab 220 Carboplatin 180 Cisplatin 146 Biopsy 146 Cyclophosphamide 138 Paclitaxel 128 Nivolumab 118 Bevacizumab 106 Gemcitabine 105 Radiotherapy 90 Dexamethasone 83 Pemetrexed 79 fludarabine 74 Docetaxel 74 atezolizumab 73 Fluorouracil 73 Doxorubicin 73 Radiation 72 Leucovorin 68 Rituximab 66 Oxaliplatin 64 venetoclax 60 Prednisone 60 durvalumab 58 Cetuximab 56 Vincristine 55 Etoposide 54 Lenalidomide 53

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Dianhydrogalactitol × 30 days × Clear all

NCT03970447 2026-06-03

GBM AGILE

Global Coalition for Adaptive Research

Phase 2/3 Recruiting

Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡